Showing results (501-510 of 545) with videos related to
Sort By:
Pageof 55
Molecular Cell|September 23, 2014
Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cellsChiara Cossetti, Nunzio Iraci, Tim R Mercer, et al.European Heart Journal|October 14, 2015
Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionDerek J Hausenloy, Rajesh Kharbanda, Michael Rahbek Schmidt, et al.Journal of Pineal Research|November 5, 2025
Melatonin Overcomes Cancer Multidrug Resistance by Downregulating ABCB1 Expression and Modulating Mitochondrial FunctionAlba López-Rodríguez, Laura Martinez-Ruiz, Raquel Morales-Gallel, et al.Genes & Development|April 19, 2011
Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesisCharles-Félix Calvo, Romain H Fontaine, Jihane Soueid, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 17, 2023
Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stressLaura Martinez-Ruiz, Javier Florido, César Rodriguez-Santana, et al.AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|October 14, 2025
A Bilingual HIV Status-Neutral Intervention to Promote Heath Equity Among GBQMSM and Transgender and Nonbinary Persons in Appalachia: Outcomes From the Appalachian Access Project Intervention TrialAmanda E Tanner, Lilli Mann-Jackson, Jorge Alonzo, et al.Progress in Community Health Partnerships : Research, Education, and Action|February 10, 2025
Using <i>ENGAGED for CHANGE</i> to Develop a Multicultural Intervention to Reduce Disparities among Sexual and Gender Minorities in AppalachiaScott D Rhodes, Amanda E Tanner, Jorge Alonzo, et al.European Journal of Heart Failure|May 23, 2022
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO<sub>2</sub> ): a randomized clinical trialPatricia Palau, Martina Amiguet, Eloy Domínguez, et al.Renal Failure|April 26, 2024
Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meetingJay L Koyner, Christian Arndt, Jaume Baldira Martinez de Irujo, et al.European Heart Journal. Quality of Care & Clinical Outcomes|February 9, 2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registryLuis R Lopes, Maria-Angela Losi, Nabeel Sheikh, et al.Pageof 55